Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas

Neuroscience Letters

Volumn 546, Issue , 2013, Pages 36-41

  Liu, Yanwei ^a   Tang, Kai ^a   Yan, Wei ^a   Wang, Yongzhi ^a   You, Gan ^a   Kang, Chunsheng ^b   Jiang, Tao ^a   Zhang, Wei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Anaplastic astrocytoma; Glioblastoma multiforme; Ki 67; MiRNA; MRNA

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; MICRORNA;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERACTIONS WITH RNA; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SURVIVAL TIME; TUMOR CELL;

APOPTOSIS; ASTROCYTOMA; CELL CYCLE; CELL LINE, TUMOR; HUMANS; KI-67 ANTIGEN; PROTEIN BINDING; RNA, MESSENGER;

EID: 84878931855     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.04.030     Document Type: Article

References (16)

1. Banks D., Wu M., Higa L.A., Gavrilova N., Quan J., Ye T., Kobayashi R., Sun H., Zhang H. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Cell Cycle 2006, 5:1719-1729.
2. Braghiroli M.I., Sabbaga J., Hoff P.M. Bevacizumab: overview of the literature. Expert Rev. Anticancer Ther. 2012, 12:567-580.
3. Desjardins A., Reardon D.A., Vredenburgh J.J. Current available therapies and future directions in the treatment of malignant gliomas. Biologics 2009, 3:15-25.
4. Dimova D.K., Dyson N.J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005, 24:2810-2826.
5. Jin Q., Zhang W., Qiu X.G., Yan W., You G., Liu Y.W., Jiang T., Wang L. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma. Chin. Med. J. (Engl.) 2011, 124:2584-2588.
6. Lee D.Y., Deng Z., Wang C.H., Yang B.B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:20350-20355.
7. Liu Y., Yan W., Zhang W., Chen L., You G., Bao Z., Wang Y., Wang H., Kang C., Jiang T. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol. Rep. 2012, 28:1013-1021.
8. Pan H.W., Chou H.Y., Liu S.H., Peng S.Y., Liu C.L., Hsu H.C. Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle 2006, 5:2676-2687.
9. Schluter C., Duchrow M., Wohlenberg C., Becker M.H., Key G., Flad H.D., Gerdes J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 1993, 123:513-522.
10. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
11. Song L., Huang Q., Chen K., Liu L., Lin C., Dai T., Yu C., Wu Z., Li J. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem. Biophys. Res. Commun. 2010, 402:135-140.
12. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996.
13. Ueki T., Nishidate T., Park J.H., Lin M.L., Shimo A., Hirata K., Nakamura Y., Katagiri T. Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene 2008, 27:5672-5683.
14. Yan W., Zhang W., You G., Zhang J., Han L., Bao Z.S., Wang Y.Z., Liu Y.W., Jiang C., Kang C.S., You Y., Jiang T. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neurol. Oncol. 2012, 14:1432-1440.
15. Zhang J.M., Sun C.Y., Yu S.Z., Wang Q., An T.L., Li Y.Y., Kong Y.L., WenJ.Y. Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis. Zhonghua Bing Li Xue Za Zhi 2011, 40:454-459.
16. Zhang W., Zhang J., Hoadley K., Kushwaha D., Ramakrishnan V., Li S., Kang C., You Y., Jiang C., Song S.W., Jiang T., Chen C.C. miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression. Neurol. Oncol. 2012, 14:712-719.